MEDI ASSIST HEALTH SER L
MEDIASSIST · General/Diversified · NSE
₹343
Current Market Price
Fair Value (DCF)
₹318
Margin of Safety
-7.3%
Updated 19h ago
YieldIQ Score
58/100
Piotroski F-Score
5/9
Economic Moat
Wide
Confidence
65%
ROE
—
Debt/Equity
0.52
WACC
11.1%
Market Cap
₹2,559 Cr
Quality & Valuation
Neutral model outputs — no recommendations.
ROCE
18.6%
Return on capital employed
EV / EBITDA
24.2×
Enterprise multiple
Debt / EBITDA
1.6×
Leverage vs earnings
Interest Coverage
12.1×
EBIT covers interest
Current Ratio
1.49×
Short-term liquidity
Asset Turnover
0.62×
Revenue per ₹ of assets
Revenue CAGR (3Y)
22.9%
3-year revenue growth
Revenue CAGR (5Y)
—
5-year revenue growth
DCF Scenario Analysis
vs CMP ₹342.55
Bear case
₹168.93
MoS -102.8%
Base case
₹317.51
MoS -7.9%
Bull case
₹366.49
MoS +6.5%
Ratio Trends
MEDIASSIST · last 4 annual periods
ROE
16.5%
ROCE
23.5%
Operating Margin
—
Debt / Equity
0.37×
PE
—
EV / EBITDA
—
Historical Financials
MEDIASSIST · Annual, last 4 years· amounts in ₹Cr unless noted
| Metric | 2022 | 2023 | 2024 | 2025 | CAGR |
|---|---|---|---|---|---|
| Revenue | ₹390 Cr | ₹502 Cr | ₹633 Cr | ₹723 Cr | +22.9% |
| EBITDA | ₹112 Cr | ₹133 Cr | ₹131 Cr | ₹178 Cr | +16.6% |
| EBIT | — | — | ₹29.0 Cr | — | +0.0% |
| PAT | ₹64.2 Cr | ₹74.1 Cr | ₹66.9 Cr | ₹90.9 Cr | +12.3% |
| EPS (diluted) | — | — | ₹3.55 | — | +0.0% |
| CFO | ₹64.5 Cr | ₹81.1 Cr | ₹66.4 Cr | ₹138 Cr | +28.9% |
| CapEx | ₹-11.8 Cr | ₹-27.7 Cr | — | ₹-45.8 Cr | — |
| FCF | ₹52.7 Cr | ₹53.4 Cr | — | ₹92.3 Cr | +20.5% |
| Total Assets | ₹602 Cr | ₹706 Cr | ₹851 Cr | ₹1158 Cr | +24.4% |
| Total Debt | ₹27.5 Cr | ₹30.7 Cr | ₹0.0 Cr | ₹204 Cr | +95.0% |
| Shareholders' Equity | ₹339 Cr | ₹384 Cr | ₹472 Cr | ₹552 Cr | +17.6% |
CAGR computed across the visible window. Signs reverse if start value is zero or negative.
Peer Comparison
MEDIASSIST vs 5 closest peers by market-cap band
| Peer | MoS | Score | Verdict | ROE | PE |
|---|---|---|---|---|---|
| BLISSGVS BLISS GVS PHARMA LTD | -46.4% | 22 | Above Fair Value | 7.7% | — |
| FISCHER FISCHER | — | — | Pending | 0.4% | — |
| IOLCP IOLCP | — | — | Pending | 6.0% | — |
| DCAL DCAL | — | — | Pending | 0.1% | — |
| ORCHPHARMA ORCHPHARMA | — | — | Pending | 7.9% | — |
Click a ticker to view its fair-value analysis.
Dividend History
No dividend events recorded for MEDIASSIST in the last 10 years.
AI Analysis Summary
Model-generated description of metrics. Not investment advice. MEDI ASSIST HEALTH SER L (MEDIASSIST.NS) trades at 342.55 vs a model fair value of 317.51, a gap of -7.3%. Piotroski F-score: 5/9. Moat l...
Read full AI analysis →Reverse DCF
Market-implied growth
What FCF growth is priced in →
Risk Analysis
Volatility & drawdown
Risk profile of MEDIASSIST →
DuPont
ROE decomposition
Why ROE is what it is →
Technicals
RSI, MACD, MAs
Reference indicators →
News & Filings
Recent activity
BSE filings + news for MEDIASSIST →
Compare
Head-to-head with peers
Compare MEDIASSIST side by side →
Run Full Interactive Analysis
Interactive DCF sliders, sensitivity heatmap, peer comparison, and more.
Analyse MEDIASSISTNow →Model estimates using publicly available data. Not investment advice. YieldIQ is not registered with SEBI as an investment adviser or research analyst. Past performance does not guarantee future results.